# Observational Study to Assess the Efficacy and Tolerability of Eptadone®, in Heroin Addicted Patients in a MMT

> **NCT02062723** · — · COMPLETED · sponsor: **L.Molteni & C. dei F.lli Alitti-Soc. di Esercizio S.p.A.** · enrollment: 515 (actual)

## Conditions studied

- Heroin Addiction

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02062723
- **Lead sponsor:** L.Molteni & C. dei F.lli Alitti-Soc. di Esercizio S.p.A.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2010-09
- **Primary completion:** 2013-02
- **Final completion:** 2013-02
- **Target enrollment:** 515 (ACTUAL)
- **Last updated:** 2014-02-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02062723

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02062723, "Observational Study to Assess the Efficacy and Tolerability of Eptadone®, in Heroin Addicted Patients in a MMT". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02062723. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*